Showing 1 - 12 results of 12 for search 'Díez-Domingo, J', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules by Sadarangani, M, Sell, T, Iro, M, Snape, M, Voysey, M, Finn, A, Heath, P, Bona, G, Esposito, S, Diez-Domingo, J, Prymula, R, Odueyungbo, A, Toneatto, D, Pollard, A
Published 2017Journal article -
6
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. by Rodgers, G, Esposito, S, Principi, N, Gutierrez-Brito, M, Diez-Domingo, J, Pollard, A, Snape, MD, Martinón-Torres, F, Gruber, W, Patterson, S, Thompson, A, Gurtman, A, Paradiso, P, Scott, D
Published 2013Journal article -
7
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform by Stuurman, AL, Carmona, A, Biccler, J, Descamps, A, Levi, M, Baum, U, Mira-Iglesias, A, Bellino, S, Hoang, U, de Lusignan, S, Bonaiuti, R, Lina, B, Rizzo, C, Nohynek, H, Díez-Domingo, J
Published 2023Journal article -
8
Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age by Snape, M, Pollard, A, Voysey, M, Finn, A, Bona, G, Esposito, S, Principi, N, Diez-Domingo, J, Sokal, E, Kieninger, D, Prymula, R, Dull, P, Kohl, I, Barone, M, Wang, H, Toneatto, D
Published 2015Journal article -
9
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of... by Iro, M, Snape, M, Voysey, M, Jawad, S, Finn, A, Heath, P, Bona, G, Esposito, S, Diez-Domingo, J, Prymula, R, Odueyungbo, A, Toneatto, D, Dull, P, Pollard, A, European Men B Vaccine Study Group
Published 2017Journal article -
10
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 ex... by Iro, M, Snape, M, Voysey, M, Jawad, S, Finn, A, Heath, P, Bona, G, Esposito, S, Diez-Domingo, J, Prymula, R, Odueyungbo, A, Toneatto, D, Dull, P, Pollard, A, European Men B Vaccine Study Group
Published 2016Journal article -
11
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedu... by Gossger, N, Snape, MD, Yu, L, Finn, A, Bona, G, Esposito, S, Principi, N, Diez-Domingo, J, Sokal, E, Becker, B, Kieninger, D, Prymula, R, Dull, P, Ypma, E, Toneatto, D, Kimura, A, Pollard, A
Published 2012Journal article -
12
Anamnestic immune response and safety of an inactivated quadrivalent influenza vaccine in primed versus vaccine-naïve children by Claeys, C, Chandrasekaran, V, García-Sicilia, J, Prymula, R, Díez-Domingo, J, Brzostek, J, Marès-Bermúdez, J, Martinón-Torres, F, Pollard, AJ, Růžková, R, Martinez, AC, Ulied, A, Valdivieso, MM, Faust, SN, Snape, MD, Friel, D, Ollinger, T, Soni, J, Schuind, A, Li, P, Innis, BL, Jain, VK
Published 2018Journal article